Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
Abstract Deficiency of adenosine deaminase (ADA, EC3.5.4.4), a housekeeping enzyme intrinsic to the purine salvage pathway, leads to severe combined immunodeficiency (SCID) both in humans and mice. Lack of ADA results in the intracellular accumulation of toxic metabolites which have effects on T cel...
Guardado en:
Autores principales: | Federico A. Moretti, Giuliana Giardino, Teresa C. H. Attenborough, Athina Soragia Gkazi, Ben K. Margetts, Giancarlo la Marca, Lynette Fairbanks, Tessa Crompton, H. Bobby Gaspar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f65c7cd9d5074750a94e03ee0d0444ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID
por: Claire Booth, et al.
Publicado: (2009) - Ada user journal
-
News from ADA congress 2007
por: Editorial team Diabetes Mellitus
Publicado: (2007) -
Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
por: Miao Miao, et al.
Publicado: (2021) -
Biografías: Charles Babbage, Augusta Ada Byron
por: José Beltrán, et al.
Publicado: (2012)